106 related articles for article (PubMed ID: 350376)
21. Carcinoembryonic antigen in human ovarian neoplasms.
Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
[TBL] [Abstract][Full Text] [Related]
22. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
23. [Estrogen and progesterone receptor systems of the endometrium in benign tumors of the uterus and ovary].
Fanchenko ND; Adamian LV; Minina LS; Khel'mund K
Akush Ginekol (Mosk); 1987 Jul; (7):26-8. PubMed ID: 3688324
[No Abstract] [Full Text] [Related]
24. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
25. Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical study.
Dietel M
Cancer Detect Prev; 1983; 6(1-2):255-62. PubMed ID: 6192920
[No Abstract] [Full Text] [Related]
26. A ten year study of ovarian tumors.
Yaker A; Benirschke K
Virchows Arch A Pathol Anat Histol; 1975; 366(4):275-86. PubMed ID: 808020
[TBL] [Abstract][Full Text] [Related]
27. The simultaneous expression of human chorionic gonadotropin and carcinoembryonic antigen in the female genital tract. Localization by immunocytochemistry.
Hayata T; Fenoglio CM; Crum CP; Richart RM
Diagn Gynecol Obstet; 1981; 3(4):309-14. PubMed ID: 7040010
[TBL] [Abstract][Full Text] [Related]
28. A feasibility study in the development of biological markers for ovarian cancer.
Waalkes TP; Rosenshein NB; Shaper JH; Ettinger DS; Woo KB; Paone JF; Gehrke CW
J Surg Oncol; 1982 Dec; 21(4):207-14. PubMed ID: 6815381
[TBL] [Abstract][Full Text] [Related]
29. Ovarian tumor-specific antigens.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
[No Abstract] [Full Text] [Related]
30. Significance of serum tumor markers in patients with carcinoma of the ovary.
Kikuchi Y; Kizawa I; Koyama E; Kato K
Obstet Gynecol; 1984 Apr; 63(4):561-6. PubMed ID: 6199705
[TBL] [Abstract][Full Text] [Related]
31. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
[No Abstract] [Full Text] [Related]
33. Significance of tumor marker determinations in the primary therapy of ovarian cancer.
Meier W; Baumgartner L; Stieber P; Hasholzner U; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2949-51. PubMed ID: 9329572
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of serial carcinoembryonic antigen levels in long-term follow-up of ovarian cancer.
Khoo SK; Whitaker S; Jones I; Mackay E
Cancer; 1979 Jun; 43(6):2471-8. PubMed ID: 455231
[TBL] [Abstract][Full Text] [Related]
35. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
[TBL] [Abstract][Full Text] [Related]
36. Zollinger-Ellison syndrome associated with ovarian mucinous cystadenocarcinoma.
Cocco AE; Conway SJ
N Engl J Med; 1975 Sep; 293(10):485-6. PubMed ID: 1152863
[No Abstract] [Full Text] [Related]
37. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
38. [Production of carcinoembryonic antigen by a benign cystadenoma of the ovary. Association with gelatinous disease of the peritoneum].
Pagé M; Bertrand G; Dalifard I; Ronceray J; Daver A; Esperandieu O; Saint-André JP
Presse Med; 1984 Feb; 13(8):503. PubMed ID: 6230636
[No Abstract] [Full Text] [Related]
39. [Steroid receptors in epithelial ovarian tumors].
Klarić P; Kanajet D; Cvrtila D
Jugosl Ginekol Perinatol; 1987; 27(3-4):77-9. PubMed ID: 3431144
[No Abstract] [Full Text] [Related]
40. Spectrum of Cystic Epithelial Tumors of the Prostate: Most Cystadenocarcinomas Are Ductal Type With Intracystic Papillary Pattern.
Paner GP; Lopez-Beltran A; So JS; Antic T; Tsuzuki T; McKenney JK
Am J Surg Pathol; 2016 Jul; 40(7):886-95. PubMed ID: 26900818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
